1. Home
  2. OGEN vs NBY Comparison

OGEN vs NBY Comparison

Compare OGEN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • NBY
  • Stock Information
  • Founded
  • OGEN 1996
  • NBY 2000
  • Country
  • OGEN United States
  • NBY United States
  • Employees
  • OGEN N/A
  • NBY 14
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • OGEN Health Care
  • NBY
  • Exchange
  • OGEN Nasdaq
  • NBY Nasdaq
  • Market Cap
  • OGEN 5.4M
  • NBY 6.3M
  • IPO Year
  • OGEN N/A
  • NBY 2007
  • Fundamental
  • Price
  • OGEN $1.27
  • NBY $1.06
  • Analyst Decision
  • OGEN
  • NBY Strong Buy
  • Analyst Count
  • OGEN 0
  • NBY 1
  • Target Price
  • OGEN N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • OGEN 241.6K
  • NBY 575.7K
  • Earning Date
  • OGEN 11-12-2025
  • NBY 11-06-2025
  • Dividend Yield
  • OGEN N/A
  • NBY N/A
  • EPS Growth
  • OGEN N/A
  • NBY N/A
  • EPS
  • OGEN N/A
  • NBY 0.41
  • Revenue
  • OGEN N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • OGEN N/A
  • NBY $23.91
  • Revenue Next Year
  • OGEN N/A
  • NBY $32.05
  • P/E Ratio
  • OGEN N/A
  • NBY $2.70
  • Revenue Growth
  • OGEN N/A
  • NBY 113.47
  • 52 Week Low
  • OGEN $1.01
  • NBY $0.46
  • 52 Week High
  • OGEN $18.90
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 46.76
  • NBY 41.74
  • Support Level
  • OGEN $1.27
  • NBY $0.99
  • Resistance Level
  • OGEN $1.45
  • NBY $1.41
  • Average True Range (ATR)
  • OGEN 0.08
  • NBY 0.17
  • MACD
  • OGEN -0.01
  • NBY -0.07
  • Stochastic Oscillator
  • OGEN 7.50
  • NBY 10.11

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: